Therapeutic Strategies to Target Multiple Kinases in Glioblastoma

E-ISSN： 1875-5992|11|8|700-711

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.11, Iss.8, 2011-10, pp. : 700-711

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

STAT3 as a Therapeutic Target for Glioblastoma

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 7, 2010-09 ,pp. : 512-519

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Strategies Targeting Glioblastoma Stem Cells

Recent Patents on Anti-Cancer Drug Discovery, Vol. 8, Iss. 3, 2013-09 ,pp. : 216-227

Bentham Science Publishers

Access to resources Recommend Favorite

The Epidermal Growth Factor Receptor as a Therapeutic Target in Glioblastoma Multiforme and other Malignant Neoplasms

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 6, 2009-07 ,pp. : 703-715

Bentham Science Publishers

Access to resources Recommend Favorite

Dehydroleucodine Induces a TP73-dependent Transcriptional Regulation of Multiple Cell Death Target Genes in Human Glioblastoma Cells

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 17, Iss. 6, 2017-06 ,pp. : 839-850

Bentham Science Publishers

Access to resources Recommend Favorite

PI3 kinase/AKT pathway as a therapeutic target in multiple myeloma

By Harvey R Donald Lonial Sagar

Future Oncology, Vol. 3, Iss. 6, 2007-12 ,pp. : 639-647

Future Medicine

Access to resources Recommend Favorite